Search Results
Search results for "Aaron Sato"
Results found for "Aaron Sato"
- Newly launched antibody libraries put hard-to-drug targets within reach
Aaron Sato, Chief Scientific Officer at Twist Bioscience, elaborates.
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Aaron McGrath from Takeda. He joins Dr. pockets and druggability 🔹 The role of cryo-EM in capturing fully activated GPCR complexes 📅 Catch Aaron
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Aaron McGrath from Takeda  🎥 Interview with Kris Borzilleri & Alison Heick Varghese from Pfizer 🎥
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
The "herb-component-target" network indicated that the ingredients of Girinimbin, Gomisin B and Asarone In conclusion, this study preliminarily revealed key active components in KXS, including Gomisin B, Asarone
- 📰 GPCR Weekly News, July 3 to 9, 2023
GPCRs, Ion Channels, and Transport Proteins (March 24 - 29, 2024) GPCR Jobs NEW Postdoctoral Fellow, Caron
- 📰 GPCR Weekly News, July 10 to 16, 2023
Senior Scientist- Membrane Technologies NEW Computational Protein Design (GPCR) Postdoctoral Fellow, Caron
- 📰 GPCR Weekly News, October 23 to 29, 2023
Kathleen Caron. Check out the weekly Classified GPCR News from October 23rd to 29th, 2023.
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Surgery Senior Scientist- Membrane Technologies Computational Protein Design (GPCR) Postdoctoral Fellow, Caron
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Kathleen Caron, as our video guest, subscribe now!
- From DNA day to GPCR genomics
S., Caron, M. G., Lefkowitz, R. J., & Strader, C. D. (1986).
- 📰 GPCR Weekly News, January 8 to 14, 2024
Kathleen M Caron and her team studied the GPER/GPR30 complex with β1-adrenergic receptor and AKAP5 in
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Kathleen Caron. Check out the weekly Classified GPCR News from October 30 to November 4, 2023.
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Slosky LM, Caron MG, Barak LS. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
Sugiura, R., Satoh, R., & Takasaki, T. (2021). ERK: a double-edged sword in cancer.
